Skip to content

Sabin Karki

Primary Navigation

  • Healthcare
  • Finance/Investing
  • Global
  • Pictures

About me

Sabin Karki

Sabin Karki

I'm a student at Johns Hopkins University studying Biomedical Engineering and Entrepreneurship & Management with a focus in Imaging & Medical Devices. Medical device inventor and aspiring physician innovator. CEO/co-founder of Benegraft, a team of engineers, surgeons, and technologists developing next-generation surgical tools for better outcomes and more efficient procedures in the reconstructive surgery space. I aspire to combine my passions for medical innovation, tech, finance, and policy to improve healthcare delivery at both a point-of-care and systemic level. My mission is to work toward a world with accessible, affordable, and high-quality healthcare for all. Find my latest thoughts on topics in medicine, investing, and more at www.sabinkarki.com Email: skarki5@jhu.edu Social: linkedin.com/in/sabinkarki IG: @sabincarkey

View Full Profile →

Contact

skarki5@jhu.edu
Healthcare, Science/Technology

Silicon Valley, Coming Soon to a Clinic Near You

In recent years, healthcare startups have seen a significant increase in interest from investors and venture capital firms in Silicon … Continue reading Silicon Valley, Coming Soon to a Clinic Near You

Nepal
Pictures

Nepal

    Continue reading Nepal

Returning to Nepal: Reflections on Kathmandu and Sipapokhare
Global, Healthcare

Returning to Nepal: Reflections on Kathmandu and Sipapokhare

As I returned to Nepal for the fifth time with my family this winter, I had the opportunity to leave the … Continue reading Returning to Nepal: Reflections on Kathmandu and Sipapokhare

Electronic Exploitation
Finance/Investing

Electronic Exploitation

In May of 2010, as the nation reeled from the global financial crisis that struck just two years earlier, markets … Continue reading Electronic Exploitation

Amid Market Turmoils, Huntington Ingalls Remains Steady
Finance/Investing

Amid Market Turmoils, Huntington Ingalls Remains Steady

As investors turn toward stabler companies amid the heightened market volatility in recent months, one corporation which should not be ignored … Continue reading Amid Market Turmoils, Huntington Ingalls Remains Steady

Ebola: The New Race for the Cure
Healthcare, Science/Technology

Ebola: The New Race for the Cure

The latest threat to international security and geopolitical stability comes not from the threat of terrorism or organized crime, but … Continue reading Ebola: The New Race for the Cure

Biotechnology: The New Frontier in Healthcare
Healthcare, Science/Technology

Biotechnology: The New Frontier in Healthcare

Biotechnology refers to the utilization of microorganisms and biologically based processes to provide novel solutions to pressing issues in society … Continue reading Biotechnology: The New Frontier in Healthcare

Can LifeLock Still Lock in Profits?
Finance/Investing

Can LifeLock Still Lock in Profits?

No one can deny that LifeLock, Inc., the $1.2 billion company at the forefront of data protection and identity theft … Continue reading Can LifeLock Still Lock in Profits?

The Exchange: Criteo, Standing in the Shadows of Giants
Finance/Investing

The Exchange: Criteo, Standing in the Shadows of Giants

You may not have heard of Criteo–but chances are, it’s probably heard of you. Criteo (NASDAQ: CRTO) isn’t the latest … Continue reading The Exchange: Criteo, Standing in the Shadows of Giants

Wearable Technology and Healthcare: An Inevitable Merger in the Making
Healthcare, Science/Technology

Wearable Technology and Healthcare: An Inevitable Merger in the Making

The data collection of consumer habits, experiences, and buyer conditions has indubitably been a point of focus for many of … Continue reading Wearable Technology and Healthcare: An Inevitable Merger in the Making

Posts navigation

Older posts
Create a website or blog at WordPress.com
Sabin Karki
Create a website or blog at WordPress.com
Cancel

 
Loading Comments...
Comment
    ×
    Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
    To find out more, including how to control cookies, see here: Cookie Policy